Search research articles
Contact Us
Filters
Showing results (51-60 of 86) with videos related to
Page
of 9
Sort By:
Diabetes & Vascular Disease Research
|
May 13, 2011
Achievement of recommended lipid and lipoprotein levels with combined ezetimibe/statin therapy versus statin alone in patients with and without diabetes
John R Guyton, D John Betteridge, Michel Farnier, et al.
Lipids in Health and Disease
|
January 14, 2014
Atorvastatin 10 mg plus ezetimibe versus titration to atorvastatin 40 mg: attainment of European and Canadian guideline lipid targets in high-risk subjects ≥65 years
Christian Constance, Ori Ben-Yehuda, Nanette K Wenger, et al.
Frontiers in Plant Science
|
May 15, 2024
Identification and expression profiling of <i>GAPDH</i> family genes involved in response to <i>Sclerotinia sclerotiorum</i> infection and phytohormones in <i>Brassica napus</i>
Jing Xu, Rongbo Wang, Xiong Zhang, et al.
Atherosclerosis
|
March 14, 2012
Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: a pooled analysis of over 21,000 subjects from 27 clinical trials
Doralisa Morrone, William S Weintraub, Peter P Toth, et al.
Journal of Clinical Lipidology
|
November 24, 2011
Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study)
Jennifer G Robinson, Christie M Ballantyne, Willa Hsueh, et al.
Human Vaccines & Immunotherapeutics
|
August 23, 2022
Immunogenicity and safety of quadrivalent and 9-valent human papillomavirus vaccines in Indian clinical trial participants
Suzanne M Garland, Manjula Anagani, Neerja Bhatla, et al.
ACS Applied Materials & Interfaces
|
November 28, 2019
Ultrahigh Frequency and Anti-Interference Optical-Mode Resonance with Biquadratic Coupled FeCoB/Ru/FeCoB Trilayers
Shouheng Zhang, Jianxin Lin, Guo-Xing Miao, et al.
Journal of Clinical Lipidology
|
February 5, 2011
Effect of ezetimibe/simvastatin vs atorvastatin on lowering levels of LDL-C and non-HDL-C, ApoB, and hs-CRP in patients with type 2 diabetes
Ruth S Weinstock, Ronald B Goldberg, John R Guyton, et al.
Diabetes, Obesity & Metabolism
|
September 5, 2018
Efficacy and safety of sitagliptin added to treatment of patients with type 2 diabetes inadequately controlled with premixed insulin
Miao Yu, R Ravi Shankar, Ruya Zhang, et al.
Experimental Neurology
|
April 10, 2024
Rejuvenating fecal microbiota transplant enhances peripheral nerve repair in aged mice by modulating endoneurial inflammation
Martin K R Svačina, Tong Gao, Alina Sprenger-Svačina, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 86) with videos related to
Sort By:
Page
of 9
Diabetes & Vascular Disease Research
|
May 13, 2011
Achievement of recommended lipid and lipoprotein levels with combined ezetimibe/statin therapy versus statin alone in patients with and without diabetes
John R Guyton, D John Betteridge, Michel Farnier, et al.
Lipids in Health and Disease
|
January 14, 2014
Atorvastatin 10 mg plus ezetimibe versus titration to atorvastatin 40 mg: attainment of European and Canadian guideline lipid targets in high-risk subjects ≥65 years
Christian Constance, Ori Ben-Yehuda, Nanette K Wenger, et al.
Frontiers in Plant Science
|
May 15, 2024
Identification and expression profiling of <i>GAPDH</i> family genes involved in response to <i>Sclerotinia sclerotiorum</i> infection and phytohormones in <i>Brassica napus</i>
Jing Xu, Rongbo Wang, Xiong Zhang, et al.
Atherosclerosis
|
March 14, 2012
Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: a pooled analysis of over 21,000 subjects from 27 clinical trials
Doralisa Morrone, William S Weintraub, Peter P Toth, et al.
Journal of Clinical Lipidology
|
November 24, 2011
Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study)
Jennifer G Robinson, Christie M Ballantyne, Willa Hsueh, et al.
Human Vaccines & Immunotherapeutics
|
August 23, 2022
Immunogenicity and safety of quadrivalent and 9-valent human papillomavirus vaccines in Indian clinical trial participants
Suzanne M Garland, Manjula Anagani, Neerja Bhatla, et al.
ACS Applied Materials & Interfaces
|
November 28, 2019
Ultrahigh Frequency and Anti-Interference Optical-Mode Resonance with Biquadratic Coupled FeCoB/Ru/FeCoB Trilayers
Shouheng Zhang, Jianxin Lin, Guo-Xing Miao, et al.
Journal of Clinical Lipidology
|
February 5, 2011
Effect of ezetimibe/simvastatin vs atorvastatin on lowering levels of LDL-C and non-HDL-C, ApoB, and hs-CRP in patients with type 2 diabetes
Ruth S Weinstock, Ronald B Goldberg, John R Guyton, et al.
Diabetes, Obesity & Metabolism
|
September 5, 2018
Efficacy and safety of sitagliptin added to treatment of patients with type 2 diabetes inadequately controlled with premixed insulin
Miao Yu, R Ravi Shankar, Ruya Zhang, et al.
Experimental Neurology
|
April 10, 2024
Rejuvenating fecal microbiota transplant enhances peripheral nerve repair in aged mice by modulating endoneurial inflammation
Martin K R Svačina, Tong Gao, Alina Sprenger-Svačina, et al.
Page
of 9